Ann Surg
-
How Does Omitting Additional Surgery After Local Excision Affect the Prognostic
Outcome of Patients With High-risk T1 Colorectal Cancer?: Erratum.
Ann Surg. 2024;279:e4.
Ann Surg Oncol
- CHIU CC
Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and
Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy
(PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results
of a Multicenter P
Ann Surg Oncol. 2024;31:2405-2407.
- BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
Local Therapy Improves Survival for Early Recurrence After Resection of
Colorectal Liver Metastases.
Ann Surg Oncol. 2024;31:2547-2556.
- CHOI JS, Kim MJ, Shin R, Park JW, et al
Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors:
Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
Ann Surg Oncol. 2024;31:2414-2424.
- SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
ASO Visual Abstract: Double Negativity of MRI-Detected and Pathologically
Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal
Cancer.
Ann Surg Oncol. 2024;31:2440-2441.
- HIRST N, McBride K, Steffens D
Psychological Interventions in Prehabilitation Randomized Controlled Trials for
Patients Undergoing Cancer Surgery: Sufficient or Suboptimal?
Ann Surg Oncol. 2024;31:2183-2186.
- BOYEV A, Newhook TE
ASO Author Reflections: Patients with Recurrence Amenable to Local Therapy for
Colorectal Liver Metastases May Experience Improved Survival.
Ann Surg Oncol. 2024;31:2600-2601.
- CHANG WJ, Chen CB, Chang YT, Wen TC, et al
ASO Author Reflections: Advancements in Laparoscopic Parenchyma-Sparing Liver
Resection: Autologous Peritoneal Patch for Middle Hepatic Vein Reconstruction in
Colorectal Liver Metastasis.
Ann Surg Oncol. 2024;31:2598-2599.
- CHOI JS, Kim MJ, Shin R, Park JW, et al
ASO Visual Abstract: Risk Factor Analysis of Lymph Node Metastasis for Rectal
Neuroendocrine Tumor: Who Needs a Radical Resection for the Rectal Neuroendocrine
Tumor 1-2 cm in Size?
Ann Surg Oncol. 2024;31:2439.
- WACH MM, Nunns G, Hamed A, Derby J, et al
Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with
Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from
Colorectal Peritoneal Metastases.
Ann Surg Oncol. 2024;31:2391-2400.
- SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous
Invasion is a Favorable Prognostic Factor for Rectal Cancer.
Ann Surg Oncol. 2024;31:2425-2438.
- BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After
Resection of Colorectal Liver Metastases.
Ann Surg Oncol. 2024;31:2606.
- SULLIVAN KM, Whelan RL, DePeralta D, Merchea A, et al
Reply to Letter to the Editor Concerning "Safety and Efficacy of Oxaliplatin
Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and
Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I
Trial in the US
Ann Surg Oncol. 2024;31:2408-2409.
Anticancer Res
- ARDJMAND D, Kubota Y, Sato M, Han Q, et al
Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells
Compared to Normal Cells.
Anticancer Res. 2024;44:929-933.
- HEGEDUS D, Szemeredi N, Gabor M, Sas J, et al
Cyclic Amines Coupled to Indole Derivatives With Improved Efflux Pump Inhibiting
Activity in Bacteria and Cancer Cells.
Anticancer Res. 2024;44:1149-1160.
- SILVA EF, Fernandes BN, Marinello P, Deminice R, et al
Pre and Post-high-intensity Interval Training Delays Colon Tumor Onset in a
Syngeneic Mouse Model.
Anticancer Res. 2024;44:1209-1217.
BMC Cancer
- DUAN J, Zhu L, Shi Y, Wang W, et al
Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line
treatment of patients with metastatic colorectal cancer: a real-world cohort
study.
BMC Cancer. 2024;24:302.
- HUANG JX, Zhang X, Tang M, Zhang Q, et al
Comprehensive evaluation of serum hepatic proteins in predicting prognosis among
cancer patients with cachexia: an observational cohort study.
BMC Cancer. 2024;24:293.
BMC Gastroenterol
- AOKI H, Takasawa A, Yamamoto E, Niinuma T, et al
Downregulation of SMOC1 is associated with progression of colorectal traditional
serrated adenomas.
BMC Gastroenterol. 2024;24:91.
Br J Cancer
- GOURIOU C, Lemanski C, Pommier P, Le Malicot K, et al
Management of non-metastatic anal cancer in the elderly: ancillary study of the
French multicenter prospective cohort FFCD-ANABASE.
Br J Cancer. 2024;130:769-776.
Br J Surg
- CUK P, Tiskus M, Moller S, Lambertsen KL, et al
Surgical stress response in robot-assisted versus laparoscopic surgery for colon
cancer (SIRIRALS): randomized clinical trial.
Br J Surg. 2024;111:znae049.
- GLYNNE-JONES R, Harrison M
Colorectal cancer para-aortic lymph node metastases: surgery should not be
considered.
Br J Surg. 2024;111:znad443.
- PEACOCK O
Colorectal cancer para-aortic lymph node metastases-surgery should be considered.
Br J Surg. 2024;111:znad445.
- PEREA J, Garcia JL, Corchete LA, Marti M, et al
Chromosomal breaks: another differential gap between early-onset and late-onset
colorectal cancers.
Br J Surg. 2024;111:znae041.
Cancer
- YANG K, Doege D, Thong MSY, Koch-Gallenkamp L, et al
Diabetes mellitus in long-term survivors with colorectal, breast, or prostate
cancer: Prevalence and prognosis. A population-based study.
Cancer. 2023 Nov 23. doi: 10.1002/cncr.35133.
Cancer Lett
- LIU C, Cheng X, Han K, Hong L, et al
A novel molecular subtyping based on multi-omics analysis for prognosis
predicting in colorectal melanoma: A 16-year prospective multicentric study.
Cancer Lett. 2024 Jan 19:216663. doi: 10.1016/j.canlet.2024.216663.
Cancer Res
- FANG L, Zhang L, Wang M, He Y, et al
Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer
Epithelial-Mesenchymal Transition.
Cancer Res. 2024;84:659-674.
- MCCOLLUM SE, Shah YM
Stressing Out Cancer: Chronic Stress Induces Dysbiosis and Enhances Colon Cancer
Growth.
Cancer Res. 2024;84:645-647.
Dis Colon Rectum
- LISKA D
Research Perspective on: Systematic Review of Neoadjuvant Immunotherapy for
Mismatch Repair Deficient Locally Advanced Colon Cancer: An Emerging Strategy.
Dis Colon Rectum. 2024 Mar 7. doi: 10.1097/DCR.0000000000003325.
- ADAMS ED, Salem JF, Burch MA, Fleshner PR, et al
Blinded Intraoperative Quantitative Indocyanine Green Metrics Associate With
Intestinal Margin Acceptance in Colorectal Surgery.
Dis Colon Rectum. 2024;67:549-557.
- FEFERMAN Y, Rosen RY, Gebran S, Yuval JB, et al
Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and
Nonoperative Management.
Dis Colon Rectum. 2024;67:496-504.
- MASPERO M, Lavryk O, Prien C, Bandi BJ, et al
Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis for Recurrent
Rectovaginal Fistula.
Dis Colon Rectum. 2024;67:e244.
- STEFFENS D, Blake J, Solomon MJ, Lee P, et al
Trajectories of Quality of Life After Pelvic Exenteration: A Latent Class Growth
Analysis.
Dis Colon Rectum. 2024;67:531-540.
- KIM HJ, Choi GS, Park JS, Park SY, et al
Long-term Complications of Laparoscopic or Robotic Lateral Pelvic Node Dissection
After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer.
Dis Colon Rectum. 2024;67:505-513.
Discov Oncol
- MAN Y, Xin D, Ji Y, Liu Y, et al
Identification and validation of a novel six-gene signature based on mucinous
adenocarcinoma-related gene molecular typing in colorectal cancer.
Discov Oncol. 2024;15:63.
Eur J Cancer
- YOSHINO T, Hooda N, Younan D, Muro K, et al
A meta-analysis of efficacy and safety data from head-to-head first-line trials
of epidermal growth factor receptor inhibitors versus bevacizumab in adult
patients with RAS wild-type metastatic colorectal cancer by sidedness.
Eur J Cancer. 2024;202:113975.
Eur J Surg Oncol
- VAN DER HULST HC, van der Bol JM, Bastiaannet E, Portielje JEA, et al
The effect of prehabilitation on long-term survival and hospital admissions in
older patients undergoing elective colorectal cancer surgery.
Eur J Surg Oncol. 2024;50:108244.
- TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
External validation of COMPASS and BIOSCOPE prognostic scores in colorectal
peritoneal metastases treated with cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy (HIPEC).
Eur J Surg Oncol. 2023;49:604-610.
Hum Pathol
- PIHLMANN KRISTENSEN M, Korsgaard U, Timm S, Hansen TF, et al
The prognostic value of tumor budding in a thoroughly characterized stage II
colon cancer population in the context of a national screening program.
Hum Pathol. 2024 Feb 28:S0046-8177(24)00033.
Int J Cancer
- HO VKY, Deijen CL, Hemmes B, van Erning FN, et al
Trends in epidemiology and primary treatment of anal squamous cell carcinoma in
the Netherlands (1990-2021).
Int J Cancer. 2024;154:1569-1578.
- JEZIORSKI K
Improving colon cancer screening in Poland. In search of the Holy Grail.
Int J Cancer. 2024 Mar 4. doi: 10.1002/ijc.34909.
- HORESH N, Emile SH, Garoufalia Z, Gefen R, et al
Trends in management and outcomes of colon cancer in the United States over
15 years: Analysis of the National Cancer Database.
Int J Cancer. 2024 Mar 7. doi: 10.1002/ijc.34910.
- ZNAOR A, Eser S, Bendahhou K, Shelpai W, et al
Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A
population-based cancer registry study.
Int J Cancer. 2024 Mar 8. doi: 10.1002/ijc.34895.
Int J Colorectal Dis
- ANDERSSON J, Angenete E, Gellerstedt M, Haglind E, et al
Developing a multivariable prediction model of global health-related quality of
life in patients treated for rectal cancer: a prospective study in five
countries.
Int J Colorectal Dis. 2024;39:35.
- WU QR, Zhao ZZ, Fan KM, Cheng HT, et al
Pulse pressure variation guided goal-direct fluid therapy decreases postoperative
complications in elderly patients undergoing laparoscopic radical resection of
colorectal cancer: a randomized controlled trial.
Int J Colorectal Dis. 2024;39:33.
- TATSUTA K, Sakata M, Iwaizumi M, Okamoto K, et al
Long-term prognosis after stapled and hand-sewn ileal pouch-anal anastomoses for
familial adenomatous polyposis: a multicenter retrospective study.
Int J Colorectal Dis. 2024;39:32.
Int J Oncol
- KAKAFIKA MG, Lyta AA, Gavriilidis GI, Tsiftsoglou SA, et al
Targeting mitochondrial bioenergetics by combination treatment with imatinib and
dichloroacetate in human erythroleukemic K?562 and colorectal HCT?116 cancer
cells.
Int J Oncol. 2024;64:42.
- SUN J, Chen S, Zang D, Sun H, et al
Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic
(Review).
Int J Oncol. 2024;64:44.
J Am Coll Surg
- MASOUD SJ, Seo JE, Singh E, Woody RL, et al
Social Vulnerability Index and Survivorship after Colorectal Cancer Resection.
J Am Coll Surg. 2024 Mar 5. doi: 10.1097/XCS.0000000000000961.
-
Discussion of Social Vulnerability Index and Survivorship after Colorectal Cancer
Resection.
J Am Coll Surg. 2024 Mar 5. doi: 10.1097/XCS.0000000000001026.
J Clin Oncol
- LORIA A, Ramsdale EE, Aquina CT, Cupertino P, et al
From Clinical Trials to Practice: Anticipating and Overcoming Challenges in
Implementing Watch-and-Wait for Rectal Cancer.
J Clin Oncol. 2024;42:876-880.
- FOKAS E, Smith JJ, Garcia-Aguilar J, Glynne-Jones R, et al
Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy
Revisited.
J Clin Oncol. 2024;42:872-875.
- BATTAGLIN F, Ou FS, Qu X, Hochster HS, et al
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With
Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.
J Clin Oncol. 2024 Mar 8:JCO2301507. doi: 10.1200/JCO.23.01507.
J Natl Cancer Inst
- BEVER AM, Hang D, Lee DH, Tabung FK, et al
Metabolomic signatures of inflammation and metabolic dysregulation in relation to
colorectal cancer risk.
J Natl Cancer Inst. 2024 Mar 1:djae047. doi: 10.1093.
Lancet Oncol
- HADDAD A, Lendoire M, Paolucci I, Kang HC, et al
Optimal imaging before local therapy of colorectal liver metastases.
Lancet Oncol. 2024;25:e99.
- GORGEC B, Sijberden JP, Swijnenburg RJ, Fretland AA, et al
Optimal imaging before local therapy of colorectal liver metastases - Authors'
reply.
Lancet Oncol. 2024;25:e101.
- GRANATA V, Petrillo A, Setola SV, Izzo F, et al
Optimal imaging before local therapy of colorectal liver metastases.
Lancet Oncol. 2024;25:e100.
- MCPHAIL S, Barclay ME, Swann R, Johnson SA, et al
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver,
pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking
Partnership (ICBP) population-based study.
Lancet Oncol. 2024;25:352-365.
- MCPHAIL S, Barclay ME, Johnson SA, Swann R, et al
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver,
pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking
Partnership (ICBP) population-based study.
Lancet Oncol. 2024;25:338-351.
- DE ANGELIS R, Demuru E, Baili P, Troussard X, et al
Complete cancer prevalence in Europe in 2020 by disease duration and country
(EUROCARE-6): a population-based study.
Lancet Oncol. 2024;25:293-307.
PLoS One
-
Expression of Concern: Cholecystectomy can increase the risk of colorectal
cancer: A meta-analysis of 10 cohort studies.
PLoS One. 2024;19:e0300484.
- GHANIPOUR L, Jansson Palmer G, Nilsson PJ, Nordenvall C, et al
Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A
phase I and III open label randomized controlled registry-based clinical trial
protocol.
PLoS One. 2024;19:e0294018.
- KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
Protocol to measure validity and reliability of colorectal, breast, cervical and
lung cancer screening questions from the 2021 National Health Interview Survey:
Methodology and design.
PLoS One. 2024;19:e0297773.
- YANG Y, Mirzaei G
Performance analysis of data resampling on class imbalance and classification
techniques on multi-omics data for cancer classification.
PLoS One. 2024;19:e0293607.
- BOUALI A, Spissu Y, Barberis A, Fadda A, et al
Phytochemical evaluation and exploration of some biological activities of aqueous
and ethanolic extracts of two species of the genus Plantago L.
PLoS One. 2024;19:e0298518.
Proc Natl Acad Sci U S A
- BONNET V, Maikranz E, Madec M, Vertti-Quintero N, et al
Cancer-on-a-chip model shows that the adenomatous polyposis coli mutation impairs
T cell engagement and killing of cancer spheroids.
Proc Natl Acad Sci U S A. 2024;121:e2316500121.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016